ArticleFrontiers in cardiovascular medicine2026
Clinical characteristics, management strategies, and survival outcomes of patients with chronic thromboembolic pulmonary hypertension in Central Asia: experience from the sole pulmonary endarterectomy center.
Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Chronic thromboembolic pulmonary hypertension (CTEPH) is a potentially curable cause of pulmonary hypertension, yet data from Central Asia, including Kazakhstan, remain scarce. We aimed to characterize real-world management strategies and outcomes of patients with CTEPH treated within a national referral program. Methods: We conducted a retrospective analysis of consecutive adult patients diagnosed with CTEPH between 2018 and 2024 at the sole national CTEPH referral center in Kazakhstan. Clinical characteristics, imaging findings, and invasive hemodynamic data were compared between patients undergoing pulmonary endarterectomy (PEA) and those receiving medical therapy alone. Pre- and post-operative changes were assessed in a subgroup of surgical patients, and long-term survival was evaluated. Results: A total of 110 patients were included (mean age 54 ± 12 years; 58% male), of whom 56 (50.9%) underwent PEA. The median delay from symptom onset to referral was 24 months. No significant differences in baseline hemodynamic parameters were observed between surgical and medical groups. Among patients with available paired data, PEA was associated with substantial improvements in pulmonary hemodynamics, right-heart function, exercise capacity, and biomarkers of cardiac stress. Over a median follow-up of 39 months, survival was numerically higher in the surgical group, although this difference did not reach statistical significance. The estimated nationally diagnosed catheter-confirmed CTEPH detection rate was low, whereas the annual number of PEA procedures increased over time. Conclusion: Outcomes of PEA in Kazakhstan fall within the ranges reported in international surgical series. These findings highlight the need for earlier diagnosis, structured post-pulmonary embolism surveillance, and centralized multidisciplinary care to improve access to curative treatment in emerging healthcare systems. The observed nationally diagnosed detection rates likely underestimate the true population burden of CTEPH.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.